[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370655-105":59,"doc-detail-370655-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","interplay-between-nrf2-and-ros-in-regulating-epithelial-mesenchymal-transition-implications-for-cancer-metastasis-and-therapy","Interplay between Nrf2 and ROS in regulating epithelial-mesenchymal transition: implications for cancer metastasis and therapy","","Epithelial-mesenchymal transition (EMT), covering developmental (Type I), wound-healing (Type II), and pathological (Type III) programs, drives cancer metastasis. This review synthesizes how the redox network between nuclear factor erythroid 2-related factor 2 (Nrf2) and reactive oxygen species (ROS) governs EMT and tumor progression. Nrf2 activates antioxidant defenses yet can promote survival and therapy resistance through Keap1-dependent degradation and phosphorylation-dependent stabilization. ROS from mitochondrial and NADPH oxidase pathways show dual roles: moderate ROS trigger EMT transcription factors and cancer stem-cell plasticity, while excessive ROS induce apoptosis and ferroptosis. By mapping spatiotemporal Nrf2-ROS-EMT regulation across tumor microenvironments, the work highlights therapeutic opportunities via redox balance modulation and pathway-specific Nrf2 inhibition in advanced cancers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/interplay-between-nrf2-and-ros-in-regulating-epithelial-mesenchymal-transition-implications-for-cancer-metastasis-and-therapy/370655/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/interplay-between-nrf2-and-ros-in-regulating-epithelial-mesenchymal-transition-implications-for-cancer-metastasis-and-therapy/370655.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does EMT contribute to cancer metastasis?","Question",{"text":113,"@type":114},"EMT enables primary tumor cells to gain invasive capabilities and disseminate to distant organs. Through phenotypic conversion of epithelial cells into mesenchymal-like states, EMT supports the metastatic cascade.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does Nrf2 play in the Nrf2–ROS network controlling EMT?",{"text":118,"@type":114},"Nrf2 maintains redox homeostasis by activating antioxidant genes, typically helping suppress EMT by neutralizing ROS and preserving epithelial integrity. However, chronic Nrf2 activation in cancer stem cells can paradoxically sustain metastatic potential through redox buffering.",{"name":120,"@type":111,"acceptedAnswer":121},"How do ROS levels influence EMT outcomes?",{"text":122,"@type":114},"Moderate ROS levels activate EMT transcription programs and promote cancer stem-cell plasticity, supporting metastasis. Excessive ROS trigger apoptosis and ferroptosis, counteracting tumor progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370655,1790834009,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Molecular Biology Reports (2025) 52:628  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1033-025-10731-9  \nREVIEW  \nInterplay between Nrf2 and ROS in regulating epithelial-mesenchymal transition: implications for cancer metastasis and therapy  \nYi Xu1 · Shuning Hu1,2 · Rui Chen1 · Sheng Xu1 · Guangyang Yu1 · Lili Ji1  \nReceived: 2 April 2025 / Accepted: 13 June 2025 / Published online: 23 June 2025 © The Author(s) 2025  \nAbstract  \nEpithelial-mesenchymal transition (EMT), including developmental (Type I), wound healing (Type II), and pathological (Type III) subtypes, constitutes a critical driver of cancer metastasis. This review analyzes the redox interplay between nuclear factor erythroid 2-related factor 2 (Nrf2) and reactive oxygen species (ROS) in EMT regulation and cancer progression. Nrf2 maintains redox homeostasis through antioxidant gene activation while paradoxically promoting tumor survival and drug resistance via Keap1-dependent degradation and phosphorylation-mediated stabilization. ROS generated through mitochondrial and NADPH oxidase pathways exhibit dual functionality: moderate levels activate EMT transcription factors to drive metastasis and cancer stem cells (CSCs) plasticity, whereas excessive ROS induce apoptosis and ferroptosis. While Nrf2 typically suppresses EMT through ROS neutralization and epithelial integrity preservation, chronic Nrf2 activation in CSCs paradoxically sustains metastatic potential through redox buffering. This synthesis delineates thespatiotemporal regulation of Nrf2-ROS-EMT networks across tumor microenvironments, emphasizing therapeutic opportunities through redox balance modulation and pathway-specific Nrf2 inhibition in advanced malignancies.  \nKeywords Epithelial-mesenchymal transition (EMT) · Nrf2 · ROS · Cancer stem cells · Oxidative stress  \nIntroduction  \nWHO’s 2023 online cancer statistics report 19.29 million new cases and 9.96 million deaths globally, with a mortality rate of 52%[1]. According to the 2023 data published online by the Chinese Center for Disease Control and Prevention, China’s national as well as local cancer burdens from 2005 to 2020 were evaluated [2] . The study estimated that the burden of cancer-related mortality in China in 2020 was 2.397800, an increase of 21.6% over 2005, and the burden of premature mortality was 56.599 million person-years,  \nYi Xu and Shuning Hu contributed equally to this work.  \n􀀍 Lili Ji [liliji79@ntu.edu.cn](liliji79@ntu.edu.cn)  \n1 Department of Pathology, Key Laboratory of Microenvironment and Translational Cancer Research, Medical School of Nantong University, Nantong, Jiangsu 226001, China  \n2 Department of Pathology, Lianyungang Affiliated Hostital Of Nanjing University of Chinese Medicine, Lianyungang, Jiangsu 222004, China  \nan increase of 5.0% . Most cancer-related mortality arises from metastatic progression rather than primary tumor burden. The infiltration and metastasis of malignant tumors are critical factors contributing to their poor prognosis. Metastasis involves a series of processes wherein primary tumor cells gradually gain invasive capabilities, colonize distant organs, and proliferate through blood, lymphatic vessels, or by directly infiltrating adjacent structures. Epithelialmesenchymal transition (EMT) plays a pivotal role in the process of tumor invasion and metastasis [3] . Therefore, elucidating the molecular mechanisms governing EMT in tumor invasion and metastasis is critical for improving cancer treatment outcomes.  \nDiscovered in 1994 [4], Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) is a critical regulator of antioxidative stress, essential for the antioxidant defense system and cellular protection against oxidative stress. Nrf2 functions as an antioxidant factor, regulating intracellular reactive oxygen species (ROS)levels. The increase in intracellular ROS levels holds great significance in biological systems. ROS exhibit dual functionality: physiological levels sustain homeos","cbCaivWS9kfxSkbr","https://ap.wps.com/l/cbCaivWS9kfxSkbr","pdf",1487762,14,"English","# Abstract\n# Keywords\n# Introduction\n## EMT and cancer metastasis\n## Nrf2, ROS, and oxidative stress\n# Key concepts and EMT classification\n## Definition of EMT","[{\"question\":\"How does EMT contribute to cancer metastasis?\",\"answer\":\"EMT enables primary tumor cells to gain invasive capabilities and disseminate to distant organs. Through phenotypic conversion of epithelial cells into mesenchymal-like states, EMT supports the metastatic cascade.\"},{\"question\":\"What role does Nrf2 play in the Nrf2–ROS network controlling EMT?\",\"answer\":\"Nrf2 maintains redox homeostasis by activating antioxidant genes, typically helping suppress EMT by neutralizing ROS and preserving epithelial integrity. However, chronic Nrf2 activation in cancer stem cells can paradoxically sustain metastatic potential through redox buffering.\"},{\"question\":\"How do ROS levels influence EMT outcomes?\",\"answer\":\"Moderate ROS levels activate EMT transcription programs and promote cancer stem-cell plasticity, supporting metastasis. Excessive ROS trigger apoptosis and ferroptosis, counteracting tumor progression.\"}]","Interplay between Nrf2 and ROS in regulating epithelial-mesenchymal transition: implications for cancer metastasis and therapy | PDF",1790189667,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7b59637602db75bb79025689bf6900e.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/723c4ad67223daf32749da7287d01cdb.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16f6621727b2047fb4379c544eb1e17e.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdc384c45b38e8fd41f9a1e906a67c0c.webp",980,1301]